Constitutive expression of hypoxia-inducible factor-lα renders pancreatic cancer cells resistant to apoptosis induced by hypoxia and nutrient deprivation

Cancer Research

Volumn 61, Issue 17, 2001, Pages 6548-6554

  Akakura, Nobuaki ^a,b   Kobayashi, Masanobu ^a   Horiuchi, Iori ^a   Suzuki, Akiko ^a,b   Wang, Jingxin ^a   Chen, Jian ^a   Niizeki, Hiroto ^a,c   Kawamura, Ken Ichi ^d   Hosokawa, Masuo ^a   Asaka, Masahiro ^b  

^a HOKKAIDO UNIVERSITY   (Japan)

^b Departments of Gastroenterology and Hematology   (Japan)

^c Cancer Medicine   (Japan)

^d HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HYPOXIA INDUCIBLE FACTOR 1ALPHA;

ANAEROBIC METABOLISM; APOPTOSIS; ARTICLE; CARCINOGENICITY; CELL HYPOXIA; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MALIGNANT TRANSFORMATION; NUTRIENT; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR VASCULARIZATION;

ANIMALS; APOPTOSIS; CARCINOMA, PANCREATIC DUCTAL; CELL DIVISION; CELL HYPOXIA; CELL SURVIVAL; DNA-BINDING PROTEINS; FRUCTOSE-BISPHOSPHATE ALDOLASE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUCOSE; GLUCOSE TRANSPORTER TYPE 1; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MICE; MICE, NUDE; MONOSACCHARIDE TRANSPORT PROTEINS; NUCLEAR PROTEINS; OXYGEN; PANCREATIC NEOPLASMS; RNA, MESSENGER; TRANSCRIPTION FACTORS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0035418621     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Blood flow. Oxygen and nutrient supply, and metabolic microenvironment of human tumors: A review
2. Targeting gene expression of hypoxic cells
3. Angiogenesis. How a tumor adapts to hypoxia
4. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension
5. Hypoxia-inducible factor 1α (HIF-1 α) protein is rapidly degraded by the ubiquitin/proteasome system under normoxic conditions
6. The hypoxic response: Huffing and HIFing
7. The molecular basis of hypoxia response pathway: Tumor hypoxia as a therapy target
8. Oncogenic alterations of metabolism
9. Expression of hypoxia-inducible factor 1: Mechanisms and consequences
10. HIF-1 α is required for solid tumor formation and embryonic vascularization
11. Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth
12. Overexpression of hypoxia-inducible factor 1 α in common human cancers and their metastasis
13. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
14. Exocrine tumors of pancreas
15. Arteriographic diagnosis of pancreas lesion
16. Gray-scale and color flow sonography of pancreatic ductal adenocarcinoma
17. Pancreatic adenocarcinoma: Designing the examination to evaluate the clinical questions
18. Prognostic significance of angiogenesis in human pancreatic cancer
19. High expression of vascular endothelial growth factor is associated with liver metastasis and a poor prognosis for patients with ductal pancreatic adenocarcinoma
20. Blockade of the epidermal growth factor receptor signaling by a novel tyrosine kinase inhibitor leads to apoptosis of endothelial cells and therapy of human pancreatic carcinoma
21. Vascular structure and microcirculation of experimental pancreatic carcinoma in rats
22. Hypoxia-inducible factor-1 α is a positive factor in solid tumor growth
23. High frequency of p53 mutations in human oral epithelial dysplasia and primary squamous cell carcinoma detected by yeast functional assay
24. The tumor suppressor VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
25. Ubiquitination of hypoxia-inducible factor requires direct binding to the β-domain of the von Hippel-Lindau protein
26. Up-regulation of hypoxia-inducible factors HIF-1α and HIF-2α under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function
27. Increased expression of hypoxia inducible factor-1a in rat and human prostate cancer
28. Modulation of hypoxia-inducible factor 1α expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: Implications for tumor angiogenesis and therapeutics
29. Remarkable tolerance of tumor cells to nutrient deprivation: Possible new biochemical target for cancer therapy
30. Up-regulation of vascular endothelial growth factor and its receptors in von Hippel-Lindau disease-associated and sporadic hemangioblastomas
31. Markedly increased amounts of messenger RNAs for vascular endothelial growth factor and placenta growth factor in renal cell carcinoma associated with angiogenesis
32. Effectiveness of discriminant analysis of serum CA 19-9 and elastase I in diagnosis of pancreatic carcinoma
33. Angiostatin generation by human pancreatic cancer
34. The hypoxic cell: A target for selective cancer therapy - Eighteenth Bruce F. Cain memorial award lecture
35. Suppression of tumor growth through disruption of hypoxia-inducible transcription
36. Growth factors, mitogens, oncogenes and the regulation of glucose transport
37. Developmental gene expression in the human fetal pancreas
38. Radioimmunoassay of aldolase A. Determination of normal serum levels and increased serum concentration in cancer patients
39. Expression of glucose transporters in human pancreatic tumors compared with increased FDG accumulation in PET study
40. Transferrin receptor induction by hypoxia: HIF-1-mediated transcriptional activation and cell-specific post-translational regulation
41. Role of hypoxia-inducible factor-1 in transcriptional activation of ceruloplasmin by iron deficiency
42. Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy
43. Hypoxic cervical cancers with low apoptotic index are highly aggressive